#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Mitochondrial DNA depletion Fungal infection Neuroendocrine carcinoma metastatic Kawasaki's disease Transient ischaemic attack Epstein-Barr virus infection Small cell lung cancer Pemphigus Adenomatous polyposis coli Von Willebrand's disease Head and neck cancer Pituitary-dependent Cushing's syndrome Dementia Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Trials in Disease Alport’s syndrome – Diagnostics Focal segmental glomerulosclerosis – Basic Information Lymphangiosarcoma – Trials in Disease Primary biliary cholangitis – Life with Disease Langerhans cell sarcoma – Life with Disease Richter’s syndrome – Trials in Disease Mast cell activation syndrome – Diagnostics Splenic marginal zone lymphoma – Diagnostics Angiosarcoma non-metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Soya-Bean Oil Refined GSKVX000000017986 Ficlatuzumab Minzasolmin Vb10.16 N-Tec Naltrexone Hydrochloride Festuca Rubra Pollen Vigabatrin Dazodalibep Lu Ag09222 Mk-1088 Xxb750 Pervi-Neo Bepranemab Enfuvirtide [14C]ZIPALERTINIB Garetosmab Kyv-101 BW-20805 More therapies…

    Learn about Your Condition

    Fragile X syndrome Pneumonia bacterial Ichthyosis Follicular lymphoma stage III Intellectual disability Rectal adenocarcinoma Tonsillitis Ventricular extrasystoles Colorectal adenoma Procedural headache Gastric cancer Cardiac sarcoidosis Labour pain Acute kidney injury Sinusitis bacterial More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Evaluation of COM701 as Maintenance Therapy for Patients with Relapsed Platinum-Sensitive Ovarian Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • HUMANISED IGG4 MONOCLONAL ANTIBODY AGAINST PVRIG
    • Saline
    France

  • Study on Erectile Dysfunction Recovery in Prostate Cancer Patients Using Relugolix

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Relugolix
    Italy

  • Evaluation of Enoxaparin for Prevention of Localized Intravascular Coagulopathy in Children with Slow-Flow Vascular Malformations Undergoing Interventional Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Vascular malformation
    Investigated Drugs:
    • Enoxaparin Sodium
    Spain

  • Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Colorectal cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Aldesleukin
    • Mesna
    • Cyclophosphamide Monohydrate
    Germany

  • Evaluation of a Single Measurement Strategy for Direct Oral Anticoagulants in Frail Older Patients with Atrial Fibrillation or Venous Thromboembolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    • Atrial fibrillation
    Investigated Drugs:
    • Lactose Monohydrate
    • Apixaban
    • Rivaroxaban
    The Netherlands

  • Study on Daridorexant for Treating Bedwetting in Adolescents

    Recruiting

    3 1 1
    Investigated Drugs:
    • Daridorexant
    Denmark
Previous Page
1 … 166 167 168 169 170 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!